Evidence map›Paper›PMID 10594007›Full record

ArticleMolecular and cellular biology2000

Definition of a T-cell receptor beta gene core enhancer of V(D)J recombination by transgenic mapping.

R K Tripathi, N Mathieu, S Spicuglia, D Payet, C Verthuy, G Bouvier, D Depetris, M G Mattei, W M HempeL, P Ferrier

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Activation of MouseJournal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  4. Article
  5. Long-Range Regulation of V(D)J Recombination.Advances in immunology · 2015
    Review
  6. Transcriptional drivers of the T-cell lineage program.Current opinion in immunology · 2012
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

R K TripathiCentre d'Immunologie de Marseille-Luminy, Institut National de la Santé et de la Recherche Médicale-Centre National de la Recherche Scientifique, 13288 Marseille, France.
N Mathieu
S Spicuglia
D Payet
C Verthuy
G Bouvier
D Depetris
M G Mattei
W M HempeL
P Ferrier
Centre d’Immunologie de Marseille-Luminy · FRCentre National pour la Recherche Scientifique et Technique (CNRST) · MAGénétique Médicale & Génomique Fonctionelle · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

V(D)J recombination in differentiating lymphocytes is a highly regulated process in terms of both cell lineage and the stage of cell development. Transgenic and knockout mouse studies have demonstrated that transcriptional enhancers from antigen receptor genes play an important role in this regulation by activating cis-recombination events. A striking example is the T-cell receptor beta-chain (TCRbeta) gene enhancer (Ebeta), which in the mouse consists of at least seven nuclear factor binding motifs (betaE1 to betaE7). Here, using a well-characterized transgenic recombination substrate approach, we define the sequences within Ebeta required for recombination enhancer activity. The Ebeta core is comprised of a limited set of motifs (betaE3 and betaE4) and an additional previously uncharacterized 20-bp sequence 3' of the betaE4 motif. This core element confers cell lineage- and stage-specific recombination within the transgenic substrates, although it cannot bypass the suppressive effects resulting from transgene integration in heterochromatic centromeres. Strikingly, the core enhancer is heavily occupied by nuclear factors in immature thymocytes, as shown by in vivo footprinting analyses. A larger enhancer fragment including the betaE1 through betaE4 motifs but not the 3' sequences, although active in inducing germ line transcription within the transgenic array, did not retain the Ebeta recombinational activity. Our results emphasize the multifunctionality of the TCRbeta enhancer and shed some light on the molecular mechanisms by which transcriptional enhancers and associated nuclear factors may impact on cis recombination, gene expression, and lymphoid cell differentiation.

Indexed as

Gene Rearrangement, beta-Chain T-Cell Antigen ReceptorGenes, ImmunoglobulinRecombination, GeneticAnimalsBase SequenceImmunoglobulin J-ChainsImmunoglobulin Variable RegionMiceMice, TransgenicMolecular Sequence DataReceptors, Antigen, T-Cell, alpha-betaT-LymphocytesImmunoglobulin J-ChainsImmunoglobulin Variable RegionReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID10594007
PMCPMC85041
OpenAlexW2102272951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.